It has been widely reported that CD133 is a reliable marker for lung CSCs by its tumorigenic capability to proliferate indefinitely, forming tumor spheres in a serum-free medium, generating an expansive progeny of non-tumorigenic cells and promptly producing tumor xenografts closely resembling the original tumor in immunocompromised mice15,37,38. The gene discussed is PROM1; the disease is neoplasm.